Clinical and molecular consequences of exon 78 deletion in DMD gene

被引:0
|
作者
Monica Traverso
Stefania Assereto
Serena Baratto
Michele Iacomino
Marina Pedemonte
Maria Cristina Diana
Marta Ferretti
Paolo Broda
Carlo Minetti
Elisabetta Gazzerro
Francesca Madia
Claudio Bruno
Federico Zara
Chiara Fiorillo
机构
[1] University of Genoa,DINOGMI
[2] University of Genoa and G. Gaslini Institute,Paediatric Neurology and Muscular Diseases Unit
[3] G. Gaslini Institute,Laboratory of Neurogenetic and Neuroscience
来源
Journal of Human Genetics | 2018年 / 63卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
We present a 13-year-old patient with persistent increase of serum Creatine Kinase (CK) and myalgia after exertion. Skeletal muscle biopsy showed marked reduction of dystrophin expression leading to genetic analysis of DMD gene by MLPA, which detected a single deletion of exon 78. To the best of our knowledge, DMD exon 78 deletion has never been described in literature and, according to prediction, it should lead to loss of reading frame in the dystrophin gene. To further assess the actual effect of exon 78 deletion, we analysed cDNA from muscle mRNA. This analysis confirmed the absence of 32 bp of exon 78. Exclusion of exon 78 changes the open reading frame of exon 79 and generate a downstream stop codon, producing a dystrophin protein of 3703 amino acids instead of 3685 amino acids. Albeit loss of reading frame usually leads to protein degradation and severe phenotype, in this case, we demonstrated that deletion of DMD exon 78 can be associated with a functional protein able to bind DGC complex and a very mild phenotype. This study adds a novel deletion in DMD gene in human and helps to define the compliance between maintaining/disrupting the reading frame and clinical form of the disease.
引用
收藏
页码:761 / 764
页数:3
相关论文
共 50 条
  • [41] A novel splicing silencer generated by DMD exon 45 deletion junction could explain upstream exon 44 skipping that modifies dystrophinopathy
    Ery Kus Dwianingsih
    Rusdy Ghazali Malueka
    Atsushi Nishida
    Kyoko Itoh
    Tomoko Lee
    Mariko Yagi
    Kazumoto Iijima
    Yasuhiro Takeshima
    Masafumi Matsuo
    Journal of Human Genetics, 2014, 59 : 423 - 429
  • [42] A recipe for the rational design of efficient antisense oligonucleotides for DMD gene exon skipping
    Wee, K. B.
    Wang, J. L.
    Chen, Y. J.
    Xiong, Q. B.
    Lai, P. S.
    Pramono, Z. A. D.
    NEUROMUSCULAR DISORDERS, 2012, 22 (9-10) : 858 - 858
  • [43] The exon junction complex is required for DMD gene splicing fidelity and myogenic differentiation
    Dylan Da Cunha
    Julie Miro
    Charles Van Goethem
    Cécile Notarnicola
    Gérald Hugon
    Gilles Carnac
    Mireille Cossée
    Michel Koenig
    Sylvie Tuffery-Giraud
    Cellular and Molecular Life Sciences, 2024, 81
  • [44] A novel splicing silencer generated by DMD exon 45 deletion junction could explain upstream exon 44 skipping that modifies dystrophinopathy
    Dwianingsih, Ery Kus
    Malueka, Rusdy Ghazali
    Nishida, Atsushi
    Itoh, Kyoko
    Lee, Tomoko
    Yagi, Mariko
    Iijima, Kazumoto
    Takeshima, Yasuhiro
    Matsuo, Masafumi
    JOURNAL OF HUMAN GENETICS, 2014, 59 (08) : 423 - 429
  • [45] Oral small molecule compounds that promote the skipping of exon 51 in the DMD gene
    Naryshkin, N. A.
    Dakka, A.
    Gabbeta, V.
    Pichardo, J.
    Woll, M. G.
    Zhang, N.
    Karp, G. M.
    Welch, E. M.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 826 - 826
  • [46] A complex rearrangement in the DMD gene determines new exon inclusion and BMD phenotype
    Cagliani, R
    Sironi, M
    Bardoni, A
    Fortunato, F
    Moggio, M
    Bresolin, N
    Comi, GP
    NEUROMUSCULAR DISORDERS, 2003, 13 (7-8) : 625 - 626
  • [47] PPMO-mediated skipping therapy of duplicated exon 2 in the DMD gene
    Gushchina, L.
    Grounds, K.
    Huang, H.
    Frair, E.
    Schnell, F.
    Hanson, G.
    Simmons, T.
    Wein, N.
    Flanigan, K.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S89 - S89
  • [48] Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials
    Popplewell, Linda J.
    Adkin, Carl
    Arechavala-Gomeza, Virginia
    Aartsma-Rus, Annemieke
    de Winter, Christa L.
    Wilton, Steve D.
    Morgan, Jennifer E.
    Muntoni, Francesco
    Graham, Ian R.
    Dickson, George
    NEUROMUSCULAR DISORDERS, 2010, 20 (02) : 102 - 110
  • [49] The exon junction complex is required for DMD gene splicing fidelity and myogenic differentiation
    Da Cunha, Dylan
    Miro, Julie
    Van Goethem, Charles
    Notarnicola, Cecile
    Hugon, Gerald
    Carnac, Gilles
    Cossee, Mireille
    Koenig, Michel
    Tuffery-Giraud, Sylvie
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 81 (01)
  • [50] What is the ocular phenotype associated with a single exon 78 deletion in Duchenne muscular dystrophy?
    Tuy Nga Brignol
    Dominique Mornet
    Cecilia Montañez
    Dora Fix Ventura
    Cyrille Vaillend
    Alvaro Rendón
    Journal of Human Genetics, 2020, 65 : 715 - 716